Indivior PLC Ordinary Shares (INDV NASDAQ) stock market data APIs
$38.8714
0.01(0%)
as of August 7, 2026
Try our APIs with
free plan!
Indivior PLC Ordinary Shares Financial Data Overview
Price chart is built with
Anychart
Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; and SUBOXONE Film, a buprenorphine and naloxone sublingual film. It also manufactures SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). In addition, the company is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. The company was formerly known as Indivior PLC. and changed its name to Indivior Pharmaceuticals, Inc. in January 2026. Indivior Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Prev. Close
38.8714
Open
38.8814
High
38.8927
Low
37.9482
52 wk Range
21.83-42.81
Market Cap
4 581 M
P/E Ratio
13.8643
Shares Outstanding
118 M
Revenue
1 331 M
EPS
1.15
Beta
1.136
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Indivior PLC Ordinary Shares (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Indivior PLC Ordinary Shares data using free add-ons & libraries
Get Indivior PLC Ordinary Shares Fundamental Data
Indivior PLC Ordinary Shares Fundamental data includes:
- Net Revenue: 1 331 M
- EBITDA: 576 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Indivior PLC Ordinary Shares Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-03
- EPS/Forecast: 0.97
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Indivior PLC Ordinary Shares News
New
INDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook
Indivior Pharmaceuticals INDV has announced a definitive agreement to merge with Supernus Pharmaceuticals SUPN in a tax-free, all-stock merger of equals. The transaction will create a leading central ...
Why Supernus Pharmaceuticals Stock Topped the Market Today
Key Points The two companies will carry the Supernus name. Supernus also published its latest quarterly earnings release.10 stocks we like better than Supernus Pharmaceuticals › Supernus Pharmaceu...
Halper Sadeh LLC is Investigating Whether LNTH, ATKR, INDV are Obtaining Fair Deals for their Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Sharehold...
Supernus Q2 Falls To Loss, Despite 32% Revenue Jump; To Merge With Indivior In All-Stock Deal
(RTTNews) - Supernus Pharmaceuticals Inc. (SUPN) Monday reported a slip to loss in the second quarter, on one-time impairment charges, interest expense and a reversal of income tax benefit to an expen...
Get Indivior PLC Ordinary Shares fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
